Celldom, Inc. logo

Celldom, Inc.

Find and study cells that make diseases incurable

8 employees · est. 2016 · San Carlos, United States

VS
RareCyte, Inc. logo

RareCyte, Inc.

A one-stop resource for Spatial Biology and Liquid Biopsy solutions.

65 employees · est. 2009 · Seattle, United States

RareCyte, Inc. is the older company (2016 vs 2009); RareCyte, Inc. is the larger of the two.

Side-by-Side Comparison

Celldom, Inc. RareCyte, Inc.
Founded
2016 2009 older
Headquarters
San Carlos, United States Seattle, United States
Employees
8 65 larger
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care, Medical Devices
Funding Stage
Seed Series Unknown
Total Funding
$1.95M $96.00M
Funding Rounds
5 6
Services
Single-cell resolution analysis, High-throughput cell analysis, Drug screening services, Quantitative gene expression analysis, Real-time data analysis Not tracked yet
Target Customers
Biotechnology companies, Pharmaceutical industry, Research laboratories, Academic institutions, Immunologists Not tracked yet
Taxonomy
Single Cell Analysis, High Throughput Technology, Cell Diversity Research, Drug Discovery, Drug Development, Oncology Applications, Immunology Applications, Stem Cell Biology, Phenotypic Data Analysis, Genomic Data Integration, Rare Cell Characterization, Biological Pathways, Nanowell Plates, TrapTx Analyzer System, Precision Medicine Spatial Biology, Liquid Biopsy, RareCyte, Precision Biology, Oncology, Immuno-oncology, Maternal-fetal Health, Cell And Gene Therapy, Rare Cell Analysis, Circulating Tumor Cells, Biomarkers, Non-Invasive Prenatal Testing, Clinical Trials, Fluorescent Imaging Systems, Isolation Of Rare Cells
Website
celldom.com rarecyte.com
Celldom, Inc. logo

About Celldom, Inc.

Celldom, Inc., founded in 2016, is at the forefront of next-generation cell analysis technology. The company's slogan, "Find and study cells that make diseases incurable," encapsulates its mission to revolutionize Biotechnology, Health Care, and Life Sciences industries. With its cutting-edge cloneX...

RareCyte, Inc. logo

About RareCyte, Inc.

RareCyte, Inc. is a prominent player in the field of Spatial Biology and Liquid Biopsy solutions, offering a comprehensive range of services to leaders across Research, Translational Medicine, and the Clinic. Headquartered in Seattle, WA, the company has been at the forefront of developing innovativ...

We will tell you when either one moves

BounceWatch watches Celldom, Inc. and RareCyte, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Celldom, Inc. and RareCyte, Inc. — by email.

Frequently Asked Questions

Celldom, Inc. — Find and study cells that make diseases incurable. RareCyte, Inc. — A one-stop resource for Spatial Biology and Liquid Biopsy solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Celldom, Inc. has raised $1.95M while RareCyte, Inc. has raised $96.00M.
Celldom, Inc. and RareCyte, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Celldom, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Celldom, Inc. on 15 Jun 2026, and RareCyte, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy